Risk of Major Adverse Cardiac Events Following Noncardiac Surgery in Patients With Coronary Stents
Author(s) -
Mary T. Hawn,
Laura A. Graham,
Joshua Richman,
Kamal M.F. Itani,
William G. Henderson,
Thomas M. Maddox
Publication year - 2013
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2013.278787
Subject(s) - medicine , mace , myocardial infarction , stent , perioperative , cardiac surgery , cardiology , odds ratio , coronary stent , surgery , retrospective cohort study , drug eluting stent , acute coronary syndrome , percutaneous coronary intervention , restenosis
Guidelines recommend delaying noncardiac surgery in patients after coronary stent procedures for 1 year after drug-eluting stents (DES) and for 6 weeks after bare metal stents (BMS). The evidence underlying these recommendations is limited and conflicting.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom